Federation des caisses Desjardins du Quebec’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
Other funds holding SYRS
BBA
1CM
XT
Federation des caisses Desjardins du Quebec's SYRS Position: Q1 2025 in Review
Federation des caisses Desjardins du Quebec sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 4,500 shares — an estimated $1.03K sold.
Federation des caisses Desjardins du Quebec first reported a position in SYRS in Q1 2024 and held it in 4 quarters. The position peaked at $24.1K in Q1 2024. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.
- Federation des caisses Desjardins du Quebec reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 4,500 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $1.03K.
- Federation des caisses Desjardins du Quebec first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
- Federation des caisses Desjardins du Quebec's Syros Pharmaceuticals, Inc. Common Stock position peaked at $24.1K in Q1 2024.
- 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2025, filed 15 May 2025.